These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6157397)

  • 41. Post-transfusion survival of hydroxyethyl starch 450/0.70 in man: a long-term study.
    Mishler JM; Ricketts CR; Parkhouse EJ
    J Clin Pathol; 1980 Feb; 33(2):155-9. PubMed ID: 6154064
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in the molecular composition of circulating hydroxyethyl starch following consecutive daily infusions in man.
    Mishler JM; Ricketts CR; Parkhouse EJ
    Br J Clin Pharmacol; 1979 May; 7(5):505-9. PubMed ID: 89855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Long term tolerance of highly dosed infusions of hydroxylethylstarch and dextran 60 in normovolemic rabbits].
    Hölscher B
    Infusionsther Klin Ernahr; 1975 Jun; 2(3):215-20. PubMed ID: 52620
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison between naturally occurring macroamylasaemia and macroamylasaemia induced by hydroxyethyl-starch.
    Dürr HK; Bode C; Krupinski R; Bode JC
    Eur J Clin Invest; 1978 Jun; 8(3):189-91. PubMed ID: 80321
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Second effect on volume after a one-time infusion of hydroxyethyl starch].
    Köhler H; Kirch W; Pitz H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1756-8. PubMed ID: 77106
    [No Abstract]   [Full Text] [Related]  

  • 46. Synthetic plasma volume expanders--their pharmacology, safety and clinical efficacy.
    Mishler JM
    Clin Haematol; 1984 Feb; 13(1):75-92. PubMed ID: 6202449
    [No Abstract]   [Full Text] [Related]  

  • 47. [The metabolism of organ cultures of cornea in TC 199 with added dextran 500 or hydroxyethyl starch 450].
    Reim M; Hesse R; Pietruschka G
    Klin Monbl Augenheilkd; 1990 Feb; 196(2):76-80. PubMed ID: 1691324
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effects of premedication, narcosis and surgery on the coagulation and fibrinolysis systems and the platelets. The influence of dextran and hydroxyethyl starch (hes) during and after operation (author's transl)].
    Popov-Cenić S; Müller N; Kladetzky RG; Hack G; Lang U; Safer A; Rahlfs VW
    Anaesthesist; 1977 Feb; 26(2):77-84. PubMed ID: 65927
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A blood substitute from hydroxyethyl starch and hemoglobin.
    Cerny LC; Cerny EL; Robach J; Reath M; Pontero L
    Appl Biochem Biotechnol; 1984; 10():151-3. PubMed ID: 6084473
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dosage and scheduling regimens for erythrocyte-sedimenting macromolecules.
    Mishler JM; Hester JP; Huestis DW; Rock GA; Strauss RG
    J Clin Apher; 1983; 1(3):130-43. PubMed ID: 6085930
    [No Abstract]   [Full Text] [Related]  

  • 51. Non-penetrating polymeric cryofixatives for ultrastructural and analytical studies of biological tissues.
    Skaer HL; Franks F; Echlin P
    Cryobiology; 1978 Oct; 15(5):589-602. PubMed ID: 82501
    [No Abstract]   [Full Text] [Related]  

  • 52. Large unit red cell cryopreservation with hydroxyethyl starch.
    Allen ED; Weatherbee L; Spencer HH; Lindenauer SM; Permoad PA
    Cryobiology; 1976 Oct; 13(5):500-6. PubMed ID: 61834
    [No Abstract]   [Full Text] [Related]  

  • 53. Avoiding an impairment of factor VIII:C by using hydroxyethyl starch with a low in vivo molecular weight.
    Treib J; Haass A; Pindur G; Grauer MT; Wenzel E; Schimrigk K
    Anesth Analg; 1997 Jun; 84(6):1391. PubMed ID: 9174332
    [No Abstract]   [Full Text] [Related]  

  • 54. Hydroxyethyl starch-induced macroamylasemia.
    Köhler H; Kirch W; Horstmann HJ
    Int J Clin Pharmacol Biopharm; 1977 Sep; 15(9):428-31. PubMed ID: 72048
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of hydroxyethyl starch and calcium on platelet activation.
    Deusch E; Kozek-Langenecker S
    Anesth Analg; 2005 May; 100(5):1538-1539. PubMed ID: 15845726
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical comparison of plasma substitutes, dextran and hydroxyethyl starch].
    Hayashi K; Higashi H
    Masui; 1975 Sep; 24(9):853-9. PubMed ID: 53296
    [No Abstract]   [Full Text] [Related]  

  • 57. [The effect of low-molecular hydroxyethyl starch and dextran 60 on the muscle oxygen supply in intensive care patients].
    Kopp KH; Kieser M; Sinagowitz E; Lund N
    Infusionsther Klin Ernahr; 1982 Feb; 9(1):44-51. PubMed ID: 6176540
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The effect of high and low molecular weight hydroxyethyl starch on the cellular composition of granulocyte concentrates].
    Aulmann HM; Schnurer U; Müller R; Stangel W; Schumacher S
    Beitr Infusionsther; 1988; 21():127-9. PubMed ID: 2462958
    [No Abstract]   [Full Text] [Related]  

  • 59. Heta, hexa, penta, tetra-starches: different organs--different effects?
    Bracht H; Radermacher P; Georgieff M; Stahl W
    Crit Care Med; 2012 Feb; 40(2):683-5. PubMed ID: 22249052
    [No Abstract]   [Full Text] [Related]  

  • 60. [Low-molecular-weight hydroxyethyl starch or low-molecular-weight dextran in acute inner ear disorders? A randomized comparative study].
    Pilgramm M; Vestner HJ; Schumann K
    Laryngol Rhinol Otol (Stuttg); 1986 Jul; 65(7):377-80. PubMed ID: 2427904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.